Reference
Piccinni C, et al. HR+/HER2- Metastatic Breast Cancer: Epidemiology, Prescription Patterns, Healthcare Resource Utilisation and Costs from a Large Italian Real-World Database. Clinical Drug Investigation : 25 Jul 2019. Available from: URL: http://doi.org/10.1007/s40261-019-00822-4
Rights and permissions
About this article
Cite this article
Burden of HR+/HER2− metastatic breast cancer substantial in Italy. PharmacoEcon Outcomes News 834, 7 (2019). https://doi.org/10.1007/s40274-019-6107-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6107-z